Aircraft manufacturers Airbus and Boeing have cut production, asking suppliers to also reduce deliveries by almost 50 percent.
In response to the coronavirus impact on the aviation industry, Airbus and Boeing have asked Indian vendors such as HAL, Dynamatic and Aequs Inc. to reduce production by one-third, the Hindu BusinessLine reported.
HAL produces doors for Airbus’ A320 aircraft and flaperons (which control a plane’s lift) for the Boeing 777 aircraft; Aequs makes 3,000 different types of products for the aircraft makers and Dynamatic supplies products for the Airbus A330 and A320.
A spokesperson for HAL told the paper the situation is being monitored and the company will make a decision on cutting production soon.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Aravind Melligeri, Chairman and CEO of Aequs said they do not foresee any relief this year, adding that there could be layoffs.
A spokesperson for Dynamatic told BL production is being reduced by 30 percent – directly as a result of Airbus cutting production. Dynamatic is a tier-I supplier for Airbus.
Airbus, which posted $552 million loss for Q1FY21, has reportedly informed vendors it is slashing production by half to 30 aircraft per month – for which suppliers would have to pull back supplies by 40 percent.
In internal communication, CEO Guillaume Faury said the company is “bleeding cash at an unprecedented speed.” The company has shut factories in many countries including the US and has laid-off at least a dozen subcontractors.Follow our full COVID-19 coverage here